Investing.com - GE HealthCare (NASDAQ: GEHC) reported first quarter EPS of $0.90, $0.01 worse than the analyst estimate of $0.91. Revenue for the quarter came in at $4.65B versus the consensus estimate of $4.89B.
Guidance
GE HealthCare sees Q2 2024 EPS of $4.20-$4.35 versus the analyst consensus of $4.30.
GE HealthCare's stock price closed at $88.94. It is up 20.34% in the last 3 months and down -2.38% in the last 12 months.
GE HealthCare saw 3 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See GE HealthCare's stock price’s past reactions to earnings here.
According to InvestingPro, GE HealthCare's Financial Health score is "great performance".
Check out GE HealthCare's recent earnings performance, and GE HealthCare's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
GEHC: A Bull or Bear Market Play?
Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios fueled by AI stock picks with a stellar performance this year... In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if GEHC is on your watchlist, it could be very wise to know whether or not it made the ProPicks AI lists.
Unlock ProPicks AI now